共 141 条
[1]
Kirpichnikov D(2002)Metformin: an update Ann Intern Med 137 25-33
[2]
McFarlane SI(2013)The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin Clin Pharmacol Ther 93 186-194
[3]
Sowers JR(2002)Interactions of Pharm Res 19 1244-1247
[4]
Stocker SL(2005)-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2) Drug Metab Pharmacokinet 20 379-386
[5]
Morrissey KM(2013)Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1 Pharmacogenetics Genomics 23 526-534
[6]
Yee SW(1994)A gene–gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin Diabetes Care 17 1100-1109
[7]
Castro RA(2008)Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study Pharmacogenetics Genomics 18 637-645
[8]
Xu L(2009)OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine Pharmacogenetics Genomics 19 497-504
[9]
Dahlin A(2002)Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin Pharmacogenetics 12 395-405
[10]
Ramirez AH(2004)Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function Drug Metab Pharmacokinet 19 239-244